Our website uses cookies to improve and personalise your experience and to display advertisements(if any). Our website may also include third-party cookies like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

J&J booster slashes Omicron hospitalisations -S.African study

J&J booster slashes Omicron hospitalisations -S.African study

WENDELL ROELF A booster dose of Johnson & Johnson Inc's single-dose COVID-19 vaccine was 84% effective at preventing hospitalisation in South African healthcare workers who became infected as the Omicron variant spread, researchers said. The real-world study, which has not been peer-reviewed, was based on a second dose of the J&J vaccine administered to 69,092 workers between November 15 and December 20. An initial course of inoculation has been shown to offer only greatly reduced protection against infection by Omicron, which is spreading quickly through many countries after first being identified in southern Africa and Hong Kong in late November. However,…
Read More
S.African study offers Omicron hope ahead of second coronavirus Christmas

S.African study offers Omicron hope ahead of second coronavirus Christmas

SOUTH African data offered a glimmer of hope on Wednesday about the severity of the Omicron coronavirus variant, but World Health Organization officials cautioned that it was too soon to draw firm conclusions as the strain spread across the globe. With the second Christmas of the pandemic days away, countries imposed new restrictions on their citizens while worrying about the damage the variant might inflict on their economies. Plans for Christmas parties and celebrations were wiped out from London to New Delhi amid the uncertainty. Omicron was first detected last month in southern Africa and Hong Kong. Preliminary data indicated…
Read More